Tamara Thomas

AZUHT-PRODUCTIONwarmup

The number of new cases and progression of diabetic retinopathy (DR) is lower than the figures reported 30 years ago for American Indian and Alaska Native individuals, according to a study published in JAMA Ophthalmology.
For this study, Dr. Stephanie Fonda and colleagues used medical data from different routine clinical operations of the Indian Health Service (IHS) teleophthalmology program in 20 US states to determine the clinical levels of DR and diabetic macular edema (DME) severity.
The study was conducted from January 1 to December 31, 2015, with a follow-up period of January 1, 2016, to December 31, 2019. Participants included people with diabetes aged 20 or older who had no evidence of DR or mild nonproliferative diabetic retinopathy (NPDR) at the start of the study. The study excluded patients with severe NPDR, proliferative DR, or DME.
The study included 8374 American Indian and Alaska Native individuals, of which 57% were women. The mean age of the participants is 53. Most patients in the study have had diabetes for more than seven years, with more than half of the population managing their diabetes with oral medication alone.
The researchers observed that of the study participants who had no signs of diabetic retinopathy at the start of the study, 18% developed some retinopathy at follow-up. In addition, 65.5% of the cases observed were mild NPDR. The findings also reveal that the cumulative incidence of proliferative diabetic retinopathy (PDR) was 0.1%, and 6.2% of patients had a step increase in DR of 2 or more.
Furthermore, the researchers found that more than 27% of the patients with mild NPDR at the start of the study had developed a more severe form of DR after follow-up, with 2.3% experiencing a step increase of 2 or more. They also found the cumulative incidence of severe/very severe NPDR in this population was 0.2%, and proliferative DR was 2.2%.
“The estimates reported here are lower than previous estimates in American Indian and Alaska Native patients. Estimates from this study are also lower than or similar to estimates of DR incidence in Hispanic American individuals.” the researchers write.
The researchers concluded that the incidence and progression of DR in AI/AN individuals was lower than 30 years ago, thus narrowing the gap in DR incidence between AI/AN individuals and other populations.
&nbsp;
Source:<a href="https://www.ajmc.com/view/estimates-of-diabetic-retinopathy-incidence-progression-lower-than-previously-reported-in-american-indians"> AJMC</a>
Journal Source:<a href="https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2802373"> JAMA Ophthalmology</a>

Katie Kosko

Trust in Medical Information Sources Varies by Race and Ethnicity

SUO 2024

Urban Health Today Editors

Dr. Kamal Golla on how to Improve Primary Care Physician and Specialist Coordination and Engagement

Public Health

Gaps in Clinical Trial Access Affect Veterans With Prostate Cancer

Latest News

Diabetic Retinopathy Incidence, Progression May be Lower Than Estimated Among AI/AN Patients

Eye Disease

“The estimates reported ... are lower than previous estimates in American Indian and Alaska Native patients."

About Us

Editorial Policy

Contributors & Partners

eNewsletters

Contact Us

Work With Us

Advertising

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Autoimmune Disease

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Lung Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

HIV Roundtable Discussions

COVID-19

Infectious Diseases

Asthma

COPD

Pulmonology

Digital Health

Workforce News

Dermatology

Gastroenterology

Kidney Disease

Neurology

Obesity

Pediatrics

Sickle Cell Disease

Video Insights

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Career Center

Subscribe